Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MTND4P26 is a nuclear pseudogene homologous to the mitochondrial gene MT-ND4. It is a non-functional segment of DNA located in the nuclear genome, derived from past mitochondrial-to-nuclear DNA transfer. Unlike the functional mitochondrial MT-ND4 gene, which encodes a critical component of complex I in the electron transport chain, MTND4P26 lacks protein-coding potential due to mutations and truncations, and therefore does not perform any biological function. It is not considered a therapeutic target, nor is it relevant to disease biology, interacting drugs, or as a molecular biomarker. Although it may be detected in genetic testing, it is an annotated pseudogene clone with no standard biological or therapeutic relevance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4 pseudogene 26 (MTND4P26).